atyr pharma (nasdaq: life) is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of physiocrine biology, a newly discovered set of physiological modulators.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

CEO

Sanjay Shukla

atyrpharma.com/ →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

Traders give 65% odds of oil holding above $100 a barrel to end of March

Spire Global: A High-Growth Space Data Platform At An Inflection Point

KEFI Gold and Copper raises £34m in placing

Exclusive: Hiscox manager faces Greek perjury charge over extradition case

Spire Healthcare surges ahead of 'put up or shut up' deadline on rumoured Bridgeport £1B offer

Centuri's Backlog Is Booming, But Its Debt and Valuation Still Loom Large

Silicon Metals Corp. Announces Appointment of Mr. Ray Wladichuk to Chief Executive Officer

Crude Oil Trade: Defensive And Tactical Stock Buying

Work From Home, Carpool and Fly Less to Combat Soaring Oil Prices, IEA Says

Work From Home, Carpool and Fly Less to Combat Soaring Oil Prices, IEA Says

Why is Planet Labs' stock soaring?

Massive News: Oracle's $553 Billion Backlog Could Make It the Most Important AI Stock of 2026, But Is It Too Late to Buy?

Airline and hospitality stocks lift FTSE 100 as oil price retreats

Best Income Stocks to Buy for March 20th

I Predicted the 50% Plunge in Robinhood Stock. Here's What I Think Will Happen Next

The Smartest Dividend Stocks to Buy With $2,000 Right Now

Micron's Dip: A Great Chance to Buy Into the AI Memory Boom?

NAVN Investors Have Opportunity to Lead Navan, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Stock Market Today: Oil Steadies as Israel Signals Restraint

ENPH Investors Have Opportunity to Lead Enphase Energy, Inc. Securities Fraud Lawsuit with the Schall Law Firm

About

Explore More

Traders give 65% odds of oil holding above $100 a barrel to end of March

Spire Global: A High-Growth Space Data Platform At An Inflection Point

KEFI Gold and Copper raises £34m in placing

Exclusive: Hiscox manager faces Greek perjury charge over extradition case

Spire Healthcare surges ahead of 'put up or shut up' deadline on rumoured Bridgeport £1B offer

Centuri's Backlog Is Booming, But Its Debt and Valuation Still Loom Large

Silicon Metals Corp. Announces Appointment of Mr. Ray Wladichuk to Chief Executive Officer

Crude Oil Trade: Defensive And Tactical Stock Buying

Work From Home, Carpool and Fly Less to Combat Soaring Oil Prices, IEA Says

Work From Home, Carpool and Fly Less to Combat Soaring Oil Prices, IEA Says

Why is Planet Labs' stock soaring?

Massive News: Oracle's $553 Billion Backlog Could Make It the Most Important AI Stock of 2026, But Is It Too Late to Buy?

Airline and hospitality stocks lift FTSE 100 as oil price retreats

Best Income Stocks to Buy for March 20th

I Predicted the 50% Plunge in Robinhood Stock. Here's What I Think Will Happen Next

The Smartest Dividend Stocks to Buy With $2,000 Right Now

Micron's Dip: A Great Chance to Buy Into the AI Memory Boom?

NAVN Investors Have Opportunity to Lead Navan, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Stock Market Today: Oil Steadies as Israel Signals Restraint

ENPH Investors Have Opportunity to Lead Enphase Energy, Inc. Securities Fraud Lawsuit with the Schall Law Firm